readthroughSign in
CompanyOLMANasdaqSan Francisco, CA

Olema Pharmaceuticals, Inc.

Olema Oncology develops estrogen receptor antagonists and degraders for breast cancer.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story